|
CCDC121 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.74145159298678E-14 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.01807451358127E-13 |
| Normal-vs-Stage2 |
2.58559995636176E-09 |
| Normal-vs-Stage3 |
3.99680288865056E-15 |
| Normal-vs-Stage4 |
<1E-12 |
| Stage1-vs-Stage2 |
3.480300E-02 |
| Stage1-vs-Stage3 |
8.651900E-02 |
| Stage1-vs-Stage4 |
9.83380000000311E-05 |
| Stage2-vs-Stage3 |
5.198800E-03 |
| Stage2-vs-Stage4 |
4.34609999999669E-05 |
| Stage3-vs-Stage4 |
4.773600E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.63613567139009E-12 |
| Normal-vs-AfricanAmerican |
2.18030038467987E-10 |
| Normal-vs-Asian |
8.78375150392685E-12 |
| Caucasian-vs-AfricanAmerican |
8.343600E-01 |
| Caucasian-vs-Asian |
1.806380E-01 |
| AfricanAmerican-vs-Asian |
5.001200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.0902390101819E-13 |
| Normal-vs-Female |
1.65645275274073E-12 |
| Male-vs-Female |
6.949000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.64268598723538E-12 |
| Normal-vs-Age(41-60Yrs) |
1.71285208239169E-12 |
| Normal-vs-Age(61-80Yrs) |
1.83009163379211E-12 |
| Normal-vs-Age(81-100Yrs) |
2.43669999999696E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.645800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.183800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.210000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.610800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.051200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.043800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.20159999955827E-07 |
| Classical-VS-Follicular |
2.984000E-04 |
| Classical-VS-Other |
8.040400E-01 |
| Classical-VS-Normal |
1.75759407028409E-12 |
| Tall-VS-Follicular |
5.75790526369246E-11 |
| Tall-VS-Other |
1.168590E-01 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
3.845400E-01 |
| Follicular-VS-Normal |
1.02529995604783E-09 |
| Other-VS-Normal |
1.138650E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.1458837191376E-13 |
| Normal-vs-N1 |
1.11022302462516E-16 |
| N0-vs-N1 |
2.643500E-04 |
|
|
